U.S. Court in New Jersey Nixes Drug Companies’ Challenge to Medicare Drug Price Negotiation Program
- May 03, 2024
A federal court in New Jersey rejected April 29 bids by Johnson & Johnson’s Janssen Pharmaceuticals Inc. and Bristol Myers Squib Co. (BMS) to block implementation of the Medicare drug price negotiation program.
ARTICLE TAGS
You must be logged in to access this content.